Results 201 to 210 of about 1,289,348 (247)
Some of the next articles are maybe not open access.

Scopolamine withdrawal syndrome

Postgraduate Medicine, 1990
As travel by air and ship becomes increasingly popular, more and more travelers are using transdermal scopolamine to avoid motion sickness. In fact, it has become almost fashionable for ocean travelers to sit on the sun deck with a patch behind the ear.
K, Saxena, S, Saxena
openaire   +2 more sources

Carisoprodol Withdrawal Syndrome

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
A 43‐year‐old man with chronic back and shoulder pain was treated with hydrocodone. He began taking excessive amounts of the drug, so his physicians stopped prescribing it. The patient then obtained the muscle relaxant carisoprodol on his own from several sources.
Roy R, Reeves   +2 more
openaire   +2 more sources

Alcohol Withdrawal Syndromes

Emergency Medicine Clinics of North America, 1990
Current studies have begun to elucidate the pathophysiology of alcoholism and its withdrawal syndrome. Newer benzodiazepines, beta-blockers, alpha-agonists, butyrophenones and calcium channel blocking agents, alone and in combination, have been studied recently in alcohol withdrawal.
openaire   +2 more sources

The alcohol withdrawal syndrome

The Lancet, 1997
The alcohol withdrawal syndrome (AWS) is a set of signs and symptoms that typically develops in alcohol-dependent people within 6–24 h of their last drink. It may occur unintentionally if abstinence is enforced by illness or injury, or deliberately if the person voluntarily stops drinking because of an alcohol-related illness, or as a prelude to ...
Hall, Wayne, Zador, Deborah
openaire   +5 more sources

The antiandrogen withdrawal syndrome

Urological Research, 1997
In 1989 the unanticipated agonist effect of antiandrogens on LNCaP prostate cancer cells was detected. A "flutamide withdrawal syndrome" was first described by Kelly and Scher [15], who reported a decrease in serum prostate-specific antigen (PSA) levels after the removal of flutamide from the treatment regimen.
M P, Wirth, S E, Froschermaier
openaire   +2 more sources

Alcohol Withdrawal Syndromes

2010
Approximately 11–15 million people report heavy alcohol use or alcohol abuse and dependence in the United States; not surprisingly, alcohol-related medical problems are commonly encountered in critically ill and injured patients. Alcohol withdrawal syndrome (AWS) consists of symptoms and signs arising in alcohol-dependent individuals, typically within ...
openaire   +1 more source

Estrogen Withdrawal Syndrome

JAMA: The Journal of the American Medical Association, 1986
Nearly a decade ago, I proposed the term "estrogen withdrawal syndrome" to emphasize the importance of health and well-being and socioeconomic impacts during and after the transition of menopause. 1 While menopause is a component of the complex process of aging, a well-recognized set of functional changes is attributable to estrogen withdrawal, such as
openaire   +2 more sources

Gabapentin Withdrawal Syndrome

Clinical Neuropharmacology, 2001
Gabapentin (GBP) has gained wide acceptance in the treatment of pain, migraine, bipolar illness, and epilepsy. It has a relatively benign side effect profile, lacks significant drug interactions, is not liver metabolized, and is renally excreted. Herein three cases are presented that demonstrate withdrawal symptoms after abrupt discontinuation of GBP ...
openaire   +2 more sources

Antiandrogen withdrawal syndrome with nilutamide

Urology, 1997
Antiandrogens are combined with medical or surgical castration to achieve total androgen blockade in metastatic prostate cancer. Discontinuation of antiandrogens at disease progression has been associated with prostate-specific antigen (PSA) decrease, symptom improvement, and occasionally objective tumor regression.
S D, Huan   +3 more
openaire   +2 more sources

Gamma-hydroxybutyrate withdrawal syndrome

Annals of Emergency Medicine, 2001
Gamma-hydroxybutyrate (GHB) withdrawal syndrome is increasingly encountered in emergency departments among patients presenting for health care after discontinuing frequent GHB use. This report describes the characteristics, course, and symptoms of this syndrome.A retrospective review of poison center records identified 7 consecutive cases in which ...
J E, Dyer, B, Roth, B A, Hyma
openaire   +2 more sources

Home - About - Disclaimer - Privacy